10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 230 filers reported holding 10X GENOMICS INC in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,095,581 | -26.0% | 3,081,105 | +0.1% | 1.95% | -20.1% |
Q2 2023 | $171,852,123 | +0.2% | 3,077,581 | +0.1% | 2.44% | -5.0% |
Q1 2023 | $171,587,110 | +223.9% | 3,075,589 | +111.6% | 2.56% | +192.8% |
Q4 2022 | $52,970,277 | +15.2% | 1,453,630 | -10.0% | 0.88% | +35.8% |
Q3 2022 | $45,998,000 | -58.2% | 1,615,093 | -33.6% | 0.64% | -56.2% |
Q2 2022 | $110,001,000 | -13.1% | 2,430,955 | +46.1% | 1.47% | +17.0% |
Q1 2022 | $126,540,000 | -32.2% | 1,663,469 | +32.7% | 1.26% | -18.5% |
Q4 2021 | $186,666,000 | +1.7% | 1,253,129 | -0.6% | 1.54% | +2.7% |
Q3 2021 | $183,601,000 | -23.7% | 1,261,171 | +2.6% | 1.50% | -17.5% |
Q2 2021 | $240,601,000 | +96.0% | 1,228,685 | +81.1% | 1.82% | +99.6% |
Q1 2021 | $122,780,000 | +89.2% | 678,341 | +48.0% | 0.91% | +104.0% |
Q4 2020 | $64,887,000 | – | 458,241 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |